Our study highlights the critical role of MGAT3 in regulating erythroid differentiation associated with the ERK/mitogen-activated protein kinase signaling pathway, which may shed light on identifying new differentiation therapy in chronic myelogenous leukemia. This evidence concerns the gene WNK2 and chronic myelogenous leukemia, BCR-ABL1 positive.